First Quarter 2026 Financial Highlights
Total revenue was
Gross profit was
Business Highlights
- Secured new orders for Black Widow™ drones from a
NATO ally. The contract was facilitated throughNATO Support and Procurement Agency (NSPA) . - Secured new orders for Black Widow™ drones from an
Asia-Pacific ally. This is the secondAsia-Pacific ally to recently order Black Widow systems for military use. - Entered a strategic partnership with Spetstechnoexport (STE), a state-owned enterprise under Ukraine’s Ministry of Defense, to accelerate collaboration on next-generation unmanned and robotic systems between
Red Cat andUkraine starting with next generation uncrewed surface vessels (USVs). Acquired Apium Swarm Robotics, Inc. , aCalifornia -based developer of distributed control systems for autonomous swarming drones and USVs.- Announced
Red Cat's definitive agreement to acquireQuaze Technologies, Inc. , a Canadian-based wireless power solutions company, removing restraints of traditional power sources to automation. This acquisition is pending clearance pursuant to the Investment Canada Act, which is anticipated to be completed inMay 2026 . - Announced manufacturing agreement between its maritime division, Blue Ops, and HADDY, to increase manufacturing of VARIANT 7 with large-scale robotic 3D printing and distributed manufacturing in specific theaters.
"We are projecting an exciting year, with increasing revenues (our target annual revenues in the short-medium term in between
"Simultaneously, we launched Blue Ops: a platform born in combat, third-generation USV. With our manufacturing facility now fully operational, we are pairing these vessels with battle-tested payloads like the ACS Bullfrog—made famous by President Trump—and our own family of drone systems. This represents the first 'Made in the
"With 2026 shaping up to be a banner year for
Balance Sheet
- Cash at
March 31, 2026 totaled$131.9 million , compared to$167.9 million atDecember 31, 2025 . - Inventory and prepaid inventory at
March 31, 2026 totaled$62.7 million , compared to$30.4 million atDecember 31, 2025 .
Target revenue
- Total annual revenue for the short- to medium-term is between
$150M and$180M .
Conference Call Details
About
Notice Regarding Forward-Looking Statements
This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will,” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Such statements include, but are not limited to, statements relating to Company's revenue guidance and financial outlook, expectations regarding gross margins and product diversity, anticipated timing of the Quaze Technologies acquisition, plans for manufacturing and strategic partnerships, expectations regarding future defense budget allocations, and the Company's ability to scale its operations the Company's revenue guidance and financial outlook, expectations regarding gross margins and product diversity, anticipated timing of the Quaze Technologies acquisition, plans for manufacturing and strategic partnerships, expectations regarding future defense budget allocations, and the Company's ability to scale its operations. Forward-looking statements are based on Red Cat’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled “Risk Factors” in the Form 10-K filed with the Securities and Exchange Commission on
Contact:
INVESTORS:
E-mail: RCAT@soleburystrat.com
NEWS MEDIA:
Phone: (347) 880-2895
Email: peter@indicatemedia.com
| Condensed Consolidated Balance Sheets (Unaudited) | |||||||
| (In thousands) | |||||||
| ASSETS | |||||||
| Cash | $ | 131,919 | $ | 167,865 | |||
| Accounts receivable, net | 10,571 | 26,155 | |||||
| Inventory, including prepaid inventory | 62,690 | 30,394 | |||||
| Prepaid expenses and other current assets | 4,482 | 2,524 | |||||
| Total current assets | 209,662 | 226,938 | |||||
| 44,012 | 24,590 | ||||||
| Property and equipment, net | 14,145 | 7,797 | |||||
| Other | 1,227 | 1,227 | |||||
| Operating lease right-of-use assets | 12,839 | 13,125 | |||||
| Total long-term assets | 72,223 | 46,739 | |||||
| TOTAL ASSETS | $ | 281,885 | $ | 273,677 | |||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
| Accounts payable and accrued expenses | $ | 15,631 | $ | 8,706 | |||
| Debt obligations - short term | 350 | 350 | |||||
| Contract liabilities and deposits | 281 | 261 | |||||
| Operating lease liabilities | 1,134 | 1,011 | |||||
| Acquisition consideration payable | 1,685 | — | |||||
| Convertible notes payable | — | 4,518 | |||||
| Total current liabilities | 19,081 | 14,846 | |||||
| Deferred income taxes | 443 | 443 | |||||
| Operating lease liabilities | 12,310 | 12,556 | |||||
| Acquisition consideration payable | 11,312 | — | |||||
| Total long-term liabilities | 24,065 | 12,999 | |||||
| Total liabilities | 43,146 | 27,845 | |||||
| Stockholders’ equity | 462,112 | 442,652 | |||||
| Accumulated deficit | (223,373 | ) | (196,820 | ) | |||
| Total stockholders’ equity | 238,739 | 245,832 | |||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 281,885 | $ | 273,677 | |||
| Condensed Consolidated Statements of Operations (Unaudited) | |||||||
| (In thousands) | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| Revenues, net | $ | 15,471 | $ | 1,630 | |||
| Cost of goods sold | 13,506 | 2,480 | |||||
| Gross profit (loss) | 1,965 | (850 | ) | ||||
| Operating Expenses: | |||||||
| Research and development | 7,972 | 3,433 | |||||
| Sales and marketing | 4,577 | 3,315 | |||||
| General and administrative | 16,718 | 4,880 | |||||
| Total operating expenses | 29,267 | 11,628 | |||||
| Operating loss | (27,302 | ) | (12,478 | ) | |||
| Interest income, net | (1,295 | ) | (55 | ) | |||
| Other expense, net | 541 | 10,700 | |||||
| Total other (income) expense, net | $ | (754 | ) | $ | 10,645 | ||
| Loss before provision for income taxes | (26,548 | ) | (23,123 | ) | |||
| Income tax expense | 5 | — | |||||
| Net loss | $ | (26,553 | ) | $ | (23,123 | ) | |
| Loss per share - basic and diluted | $ | (0.22 | ) | $ | (0.27 | ) | |
| Weighted average shares outstanding - basic and diluted | 120,846 | 85,506 | |||||
| Condensed Consolidated Statements of Cash Flows (Unaudited) | |||||||
| (In thousands) | |||||||
| Three months ended | |||||||
| 2026 | 2025 | ||||||
| Cash Flows from Operating Activities | |||||||
| Net loss | $ | (26,553 | ) | $ | (23,123 | ) | |
| Adjustments to reconcile net loss to net cash used in operations: | |||||||
| Stock based compensation | 4,817 | 1,599 | |||||
| Depreciation and amortization of intangible assets | 812 | 588 | |||||
| Convertible notes payable fair value adjustment | 867 | 10,700 | |||||
| Gain on extinguishment of convertible notes payable | (326 | ) | — | ||||
| Changes in operating assets and liabilities, net of acquisitions | |||||||
| Accounts receivable | 15,584 | (1,065 | ) | ||||
| Inventory | (27,078 | ) | (904 | ) | |||
| Prepaid inventory | (5,218 | ) | (2,611 | ) | |||
| Prepaid expenses and other | (1,958 | ) | (519 | ) | |||
| Operating lease right-of-use assets and liabilities | 163 | 13 | |||||
| Contract liabilities and deposits | 20 | (7 | ) | ||||
| Accounts payable | 5,623 | (531 | ) | ||||
| Accrued expenses | 1,302 | (47 | ) | ||||
| Net cash used in operating activities | (31,945 | ) | (15,907 | ) | |||
| Cash Flows from Investing Activities | |||||||
| Purchases of property and equipment | (6,783 | ) | (273 | ) | |||
| Net cash used in investing activities | (6,783 | ) | (273 | ) | |||
| Cash Flows from Financing Activities | |||||||
| Proceeds from issuance of convertible notes payable | — | 15,000 | |||||
| Debt issuance costs | — | (567 | ) | ||||
| Payments of taxes withheld upon vesting of employee stock awards | (239 | ) | — | ||||
| Proceeds from exercise of stock options | 240 | 316 | |||||
| Proceeds from exercise of warrants | 2,781 | — | |||||
| Net cash provided by financing activities | 2,782 | 14,749 | |||||
| Net decrease in Cash | (35,946 | ) | (1,431 | ) | |||
| Cash, beginning of period | 167,865 | 9,154 | |||||
| Cash, end of period | $ | 131,919 | $ | 7,723 | |||
| Reconciliation of Non-GAAP adjusted EBITDA (Unaudited) | |||||||
| (In thousands) | |||||||
| Three Months Ended | |||||||
| 2026 | 2025 | ||||||
| Net loss | $ | (26,553 | ) | $ | (23,123 | ) | |
| Adjustments: | |||||||
| Income tax (benefit) expense | 5 | — | |||||
| Interest (income) expense, net | (1,295 | ) | (55 | ) | |||
| Depreciation and amortization | 812 | 588 | |||||
| Other (income) expense, net(1) | 541 | 10,700 | |||||
| Impairment loss(2) | — | — | |||||
| Restructuring costs(3) | — | 27 | |||||
| Stock based compensation | 4,817 | 1,599 | |||||
| Non-routine legal expenses(4) | 126 | 41 | |||||
| Other adjustment items(5) | — | — | |||||
| Adjusted EBITDA | $ | (21,547 | ) | $ | (10,223 | ) | |
(1) Other (income) expense, net. Represents convertible note payable fair value adjustment, gain on extinguishment of convertible notes payable, and other income, net.
(2) Impairment loss. Represents an impairment charge to goodwill and or intangible assets.
(3) Restructuring costs. Represents restructuring costs incurred for cost reduction actions which may include employee termination costs, facility shut-down related costs, costs for unused, excess or exited facilities.
(4) Non-routine legal expenses. Represents external legal expenses incurred in connection with pending legal settlements and other legal related matters.
(5) Other adjustment items. Represents other adjustments that are non-recurring and outside the normal course of operations that do not readily fall into any other categories.
Notice Regarding Use of Non-GAAP Financial Measures
This press release contains Non-GAAP financial measures, including Adjusted EBITDA (which excludes, among other things, income tax expenses (benefits), net interest (income) expenses, depreciation and amortization, other expenses (income), impairment losses, restructuring related items, stock based compensation expense, non-routine legal expenses, and any other one-time adjustments. The Company’s management uses these non-GAAP financial measures, along with the most directly comparable GAAP financial measures, in evaluating the Company’s performance, capital resources and cash flow. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in compliance with GAAP, and investors should carefully evaluate the Company’s financial results calculated in accordance with GAAP and reconciliations to those financial results. In addition, non-GAAP financial measures as reported by the Company may not be comparable to similarly titled amounts reported by other companies. As appropriate, the most directly comparable GAAP financial measures and information reconciling these non-GAAP financial measures to the Company’s financial results prepared in accordance with GAAP are included in this news release.
Source: